Top 10 Value Stocks To Own Right Now

Investment company Harbour Capital Advisors, LLC buys Amazon.com, Alphabet, Intuit, Target, Micron Technology, Eli Lilly and Co, Citizens Financial Group, Alibaba Group Holding, Equifax, Alphabet, sells Gogo, Apple, Vanguard Total Stock Market, Broadcom, PDC Energy during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, Harbour Capital Advisors, LLC. As of 2016-12-31, Harbour Capital Advisors, LLC owns 163 stocks with a total value of $135 million. These are the details of the buys and sells.

New Purchases: INTU, TGT, MU, CFG, BABA, EFX, TTM, CRTO, GPK, HDS, Added Positions: AMZN, GOOG, LLY, GOOGL, VBK, CVE, EWW, DY, V, KHC, Reduced Positions: VTI, IWF, SLB, DG, DAL, CVS, LAD, PAGP, SFM, FDX, Sold Out: GOGO, AAPL, AVGO, PDCE, T, ARMK, VWO, NXPI, FANG, WDC,

For the details of Harbour Capital Advisors, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Harbour+Capital+Advisors%2C+LLC

These are the top 5 holdings of Harbour Capital Advisors, LLCChevron Corp (CVX) – 57,856 shares, 5.04% of the total portfolio. Shares reduced by 0.69%iShares Russell 1000 Value (IWD) – 43,240 shares, 3.58% of the total portfolio. Shares reduced by 0.8%iShares Russell 1000 Growth (IWF) – 37,853 shares, 2.94% of the total portfolio. Shares reduced by 15.04%JPMorgan Chase & Co (JPM) – 31,329 shares, 2% of the total portfolio. Shares reduced by 1.14%iShares Russell 1000 (IWB) – 20,025 shares, 1.84% of the total portfolio. Shares reduced by 1.96%New Purchase: Intuit Inc (INTU)

Harbour Capital Advisors, LLC initiated holdings in Intuit Inc. The purchase prices were between $105.28 and $118.39, with an estimated average price of $111.97. The stock is now traded at around $123.18. The impact to the portfolio due to this purchase was 0.34%. The holdings were 4,036 shares as of 2016-12-31.

Top 10 Value Stocks To Own Right Now: The ExOne Company(XONE)

Advisors’ Opinion:

  • [By Paul Ausick]

    Short interest in The ExOne Co. (NASDAQ: XONE) rose by 1.6% to 2.38 million shares. About 22.1% of the company’s shareswere short. ExOne’s share price fell by nearly 13% in the two weeks. The stock’s 52-week range is $6.60 to $16.15, and shares closed at $11.11 on Friday, down about 0.7% for the day. Days to cover fell from 17 to 13.

  • [By Peter Graham]

    A long term performance chart shows Voxeljet AGalong with other small cap 3D printing stocks like ExOne Co (NASDAQ: XONE), 3D Systems Corporation (NYSE: DDD) and Stratasys, Ltd (NASDAQ: SSYS) all peaking around 2013-2014, but also showing some signs of life in recent months:

  • [By Paul Ausick]

    Short interest in The ExOne Co. (NASDAQ: XONE) fell by 1.7% to 1.86 million shares. About 19.8% of the company’s shares were short. ExOne’s share price jumped by about 14.2% in the period. The stock’s 52-week range is $6.72 to $14.43, and shares closed at $10.39 on Wednesday, up about 1.6% for the day. Days to cover rose from eight to 11.

  • [By Peter Graham]

    A long term performance chart shows shares of Stratasys, Ltd along with other small cap 3D printing stocks like 3D Systems Corporation (NYSE: DDD), ExOne Co (NASDAQ: XONE)and Voxeljet AG (NYSE: VJET) all peaking a few years and all showing some signs of stabilization over the past year:

Top 10 Value Stocks To Own Right Now: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Chris Lange]

    Immunomedics, Inc. (NASDAQ: IMMU) saw its shares rise after the firm sent out a letter to shareholders imploring them to vote for its director nominees at the upcoming annual stockholders meeting on February 16. The board of directors is making this request because it is currently waging a proxy contest with venBio SelectAdvisor.

Top 10 Value Stocks To Own Right Now: Transdigm Group Incorporated(TDG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    TransDigm Group (TDG) soared to the top of the S&P 500 today after beating earnings and sales forecasts.

    Agence France-Presse/Getty Images

    TransDigm gained 6.5% to $245.88 today, while the S&P 500 finished little changed at2,293.08.

    TransDigm reported a profit of $2.57, beating forecasts for$2.47, on sales of $814 million, topping the Street consensus for $804.5 million.

    TransDigm’s market capitalization rose to $13.1 billion today from $12.3 billion yesterday.

  • [By Mitchell Clark]

     This firm is not a household name. This Cleveland-based company, in the aerospace parts business, has approximately $12.0 billion in market capitalization on the stock market.

    TransDigm Group Incorporated (NYSE:TDG) doesn’t pay a regular dividend, but often pays out one-time, special dividends. In the past, they’ve been pretty hefty.

    Selling pumps, motors, power systems, and basically anything you can image that’s part of an aircraft, TDG’s been growing its financial results at a good clip.

  • [By Ben Levisohn]

    TransDigm Group (TDG) tumbled to the bottom of the S&P 500 today after Citron Research doubled down on its assertion that the company is a manufacturing version of Valeant Pharmaceuticals International (VRX).

    Agence France-Presse/Getty Images

    TransDigm Groupdropped 4.2% to $231.37, while the S&P 500 rose 0.3% to 2,372.60.

    From Citron’s report on TransDigm:

    Citron predicts that after this report makes its rounds, TransDigms (NYSE:TDG) days of exploiting and deceiving the Federal Government are numbered.

    Valeant Pharmaceuticals has recently hit prices lower than some ever thought was imaginable. As Citron observes today, at $12 per share, that stock is down over 95% from its highs just months prior to Citrons reporting on Philidor. The questions then turn to: How did so many smart people get it so wrong? and When could this possibly happen again?”

    While we are sure there will be many books written on these questions, we can narrow it down to a small checklist. The smart money got Valeant wrong by:

    Disregarding a roiling political climate disrupting “business as
    usual” Underestimating the financial frailty of a roll up Discounting the dangers of a small customer base (PBMs) Putting too much trust in the companys CEO…

    All points in the above checklist apply directly to TransDigm.

    TransDigm Group’s market capitalization fell to $12.2 billion today from $12.8 billion yesterday. It reported net income of $583 million on sales of $3.2 billion in 2016.

  • [By Ben Levisohn]

    TransDigm (TDG) sunk to the bottom of the S&P 500 today after its earnings topped the Street consensus but its guidance disappointed.

    Shares of TransDigm fell 7.1% to $$252.96 today, while the S&P 500 finished little changed.

    TransDigm reported a profit of $3.29 a share, better than the $3.20 expect by analysts, on sales of$875.2 million, below forecasts for $884.26 million. Worse still, the airplane-part manufacturer said it would earn $11.84 to $12.12 a share in fiscal 2017, below forecasts for$12.80.

    TransDigm’s market cap fell to $13.5 billion today, from $14.5 billion on Friday.

  • [By Lee Jackson]

    Transdigm Group Inc. (NYSE: TDG) had a director at the company step in and buy stock in a big way last week. That director purchased a total of 91,000 shares of the stock at prices ranging from $247.16 to $247.89. The total for the trade came in near $22.7 million.The company designs, produces and supplies aircraft components in the United States. Its stock closed trading last Friday at $251.488.

  • [By Lee Jackson]

    Warren Buffett and Berkshire Hathaway were big buyers this week, as they added shares of aircraft components maker Transdigm Group Inc. (NYSE: TDG), forwhich they also serve as a director. Berkshire Hathaway bought 104,967 shares of the stock at prices that ranged from $231.18 to $234.40 per share. The total for the trade came in at a massive $25 million. The shares closed trading last Friday at $240.05, so the timing looks good. The 52-week trading range for the stock is $214.65 to $294.38. The Wall Street consensus price target is pegged at $295.24.

Top 10 Value Stocks To Own Right Now: Energy Select Sector SPDR ETF (XLE)

Advisors’ Opinion:

  • [By ]

    When we compare the energy sectors recent run to the S&P 500, its not even close. The Energy Select Sector SPDR (NYSE:XLE) has jumped more than 25% since Sept. 1. The S&P is up a 15% over the same timeframe.

  • [By Craig Jones]

    Joe Tigay spoke on Bloomberg Markets about his trading strategy in Energy Select Sector SPDR (ETF) (NYSE: XLE).

    He said crude oil has been trading between $50 and $55 lately and every time it drops close to $50, domestic supply decreases and the price moves higher. He believes crude oil could move higher from its current price level and he wants to set up a bullish strategy. He wants to buy Energy Select Sector SPDR (ETF) shares and sell the April $73 call for $1.40.

  • [By Ben Levisohn]

    Shares of ExxonMobil have ticked up 0.1% to $81.89 at 3:17 p.m. today, while Chevron has risen 0.5% to $108.62. The Energy Select Sector SPDR (XLE) has advanced 0.1% to $69.31.

  • [By Ben Levisohn]

    Yesterday, ExxonMobil (XOM) reported earnings that didn’t do much to excite investors, and today its shares are falling again, making my bearish call from Jan. 14 look better and better. Strategas Research Partners’ Chris Verrone and team note that Exxon–the largest stock in the Energy Select Sector SPDR ETF (XLE) with a 16% weighting–continues to weigh on the energy sector:

  • [By Ben Levisohn]

    Shares of ExxonMobil have advanced 0.8% to $81.89 at 2:02 p.m. today, while the Energy Select Sector SPDR ETF (XLE) has advanced 0.4% to $68.07.

     

Top 10 Value Stocks To Own Right Now: TripAdvisor, Inc.(TRIP)

Advisors’ Opinion:

  • [By Peter Graham]

    Online travel stock Tripadvisor Inc (NASDAQ: TRIP) reportedQ1 2017 earnings after the market closed on Tuesday with shares up in afterhours /premarket trading. Q1 revenue rose 6% (or 7% on a constant currency basis) to $372 million as hotel revenue grew 4% to $314 million and non-hotel revenue rose 18% to $58 million.Net income was $13 million versus $29 million. Key business metrics cited in the earnings report included:

  • [By Peter Graham]

    A long term performance chart shows Angie’s List basically back to breakeven while other online review stocks like small cap Yelp Inc (NYSE: YELP) and mid cap Tripadvisor Inc (NASDAQ: TRIP) have performed a bit better with mid capacquirer IAC has been a better performer:

  • [By Ben Levisohn]

    TripAdvisor (TRIP) tumbled to the bottom of the S&P 500 today, a reversal of yesterday’s big gain following the news thatExpedia (EXPE) would participate in its Instant Booking program.

    Agence France-Presse/Getty Images

    TripAdvisordropped 5.1% to $46.28 today, while the S&P 500 declined 0.3% to 2,265.18.

    In a note published yesterday, SunTrust Robinson Humphrey’s Rodney Hull and team called the announcement a “positive for [the] platform” but worried about the fact that “shopper growth and monetization have been muted.” They explain:

    Ultimately, TripAdvisor is seeking to improve its revenue per shopper which trails its OTA peers who earn 4-5x more per shopper by driving booking and repeat booking activity on their sites. On a positive note, TripAdvisor stated that US trends improved through the third quarter and that transaction revenue and rev/shopper turned positive in October. Further, green shoots in app bookings and vaulted credit cards are noteworthy. However, the dual headwinds of mobile and the IB transition continue to negatively impact financials as well as the “flywheel” for shopper growth and visibility into improving growth remains limited, aside from easing comps. We have a positive view of the company’s longer-term monetization opportunity, but we await further signs of inflection in growth and profitability, which may follow a larger ad campaign. Recall, the company reduced its margin outlook for 2017 on the 3Q call as it will likely look to increase paid marketing spend and invest revenue per shopper gains to restart the flywheel

    TripAdvisor’s market capitalization fell to $6.7 billion today from $7.1 billion yesterday. It reported net income of $198 million on sales of $1.5 billion in 2015.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading.
    Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session.
    Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session.
    Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Value Stocks To Own Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

  • [By Jim Robertson]

    The earnings report summarized the following recent milestones:

    The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.

    Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.

  • [By Teresa Rivas]

    Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.

    Pixabay

    As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.

    Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:

    While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.

    Jazz shares are up 8.9% to $153.2o at recent check.

Top 10 Value Stocks To Own Right Now: Helen of Troy Limited(HELE)

Advisors’ Opinion:

  • [By Teresa Rivas]

    Helen of Troy (HELE) is trading lower Friday, after reporting a mixed first quarter.

    The personal care products company said it earned $1.27 a share on revenue that rose 0.8% to $347.9 million. Analysts were expecting earnings of $1.17 per share on revenue of $356.1 million. Gross profit margin increased 2.3 percentage points to 43.8%, while cash flow from operations climbed from $37.8 million in the year ago period to $41.7 million.

    For the full year, Helen of Troy expects to earn between $5.85 to $6.35 a share on revenue of $1.57 billion to $1.62 billion. Analysts are modeling for earnings of $6.12 a share on revenue of $1.6 billion. However the company also warned that it expects a decline in sales for its nutritional supplement division.

    Jefferies Trevor Young reiterated a Buy rating and $114 price target on the stock today:

    Despite the 1Q revenue miss and ~30bps (~$4m) expected incremental FX headwinds, management maintained its FY revenue and adjusted EPS guidance (GAAP EPS came down $0.23 on the high and low end due to $6.6m of after tax non-cash asset impairment and patent litigation charges). Embedded in this guidance is the assumption of beauty coming in at the low end of the previous -7% to -12% range, and nutritional declining MSD (vs. flat to LSD positive growth previously). We believe this implies that housewares (MSD positive growth guidance previously) and health & home (LSD positive growth previously) would have to perform incrementally better than prior expectations, which we view as a positive.

    The shares are down 3.3% to $99.31 in recent trading.

Top 10 Value Stocks To Own Right Now: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

Top 10 Value Stocks To Own Right Now: Paychex Inc.(PAYX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Paychex, Inc. (NASDAQ: PAYX) reported better-than-expected earnings for its third quarter on Wednesday.

    Paychex posted Q3 earnings of $0.56 per share on revenue of $795.8 million. However, analysts were expecting earnings of $0.54 per share on revenue of $799.0 million.

  • [By Monica Gerson]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Paychex, Inc. (NASDAQ: PAYX) is estimated to report its quarterly earnings at $0.49 per share on revenue of $751.52 million. Paychex shares rose 1.10 percent to close at $56.14 on Wednesday.
    Wall Street expects Micron Technology, Inc. (NASDAQ: MU) to post a quarterly loss at $0.09 per share on revenue of $2.95 billion. Micron shares rose 0.76 percent to $13.29 in after-hours trading.
    Pier 1 Imports Inc (NYSE: PIR) reported a wider-than-expected loss for its first quarter and issued a weak outlook. Pier 1 Imports shares dropped 6.07 percent to $5.11 in the after-hours trading session.
    Analysts are expecting McCormick & Company, Incorporated (NYSE: MKC) to have earned $0.74 per share on revenue of $1.06 billion in the latest quarter. McCormick shares fell 0.59 percent to $102.10 in after-hours trading.

    Posted-In: Stocks To WatchEarnings News Guidance Pre-Market Outlook Markets Trading Ideas

  • [By Monica Gerson]

     

    Darden Restaurants, Inc. (NYSE: DRI) is estimated to report its quarterly earnings at $1.08 per share on revenue of $1.81 billion.
    ConAgra Foods Inc (NYSE: CAG) is expected to report its quarterly earnings at $0.52 per share on revenue of $2.89 billion.
    Paychex, Inc. (NASDAQ: PAYX) is projected to report its quarterly earnings at $0.49 per share on revenue of $751.52 million.
    Micron Technology, Inc. (NASDAQ: MU) is expected to post a quarterly loss at $0.09 per share on revenue of $2.95 billion.
    McCormick & Company, Incorporated (NYSE: MKC) is estimated to report its quarterly earnings at $0.74 per share on revenue of $1.06 billion.
    Constellation Brands, Inc. (NYSE: STZ) is expected to report its quarterly earnings at $1.51 per share.
    Schnitzer Steel Industries, Inc. (NASDAQ: SCHN) is estimated to report its quarterly earnings at $0.18 per share on revenue of $356.41 million.
    Franklin Covey Co. (NYSE: FC) is expected to post its quarterly earnings at $0.08 per share on revenue of $49.89 million.
    Lindsay Corporation (NYSE: LNN) is projected to report its quarterly earnings at $0.99 per share on revenue of $148.43 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

  • [By Monica Gerson]

    Paychex, Inc. (NASDAQ: PAYX) is projected to report its quarterly earnings at $0.50 per share on revenue of $751.20 million.

    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.26 per share on revenue of $362.62 million.

  • [By WWW.THESTREET.COM]

    Wednesday brings earnings from General Mills (GIS) , which will likely be disappointing, Paychex (PAYX) , which will likely be good, and an analyst meeting from Cisco Systems (CSCO) , which needs to show investors it still has more growth ahead.

Top 10 Value Stocks To Own Right Now: Grow Solutions Holdings, Inc. (GRSO)

Advisors’ Opinion:

  • [By Javier Hasse]

    Grow Solutions Holdings Inc (OTC: GRSO) acquired Keys Organic and Hydroponic Supply.

    "What we are starting to see here is aggregation in the highly-fragmented hydroponic and grow supply industry. Most of these stores, including Keys Organic and Hydroponic Supply, are typically local or regional — This results in a very fragmented market."
    "We saw this [aggregation] happen with grocery stores, the finance industry, auto dealerships — Bigger names come in. So, instead of Bob's Ford Motor Company (NYSE: F) Dealership or Fred'sGeneral Motors Company (NYSE: GM) outlet, you'll get companies likeAutoNation, Inc. (NYSE: AN) come in, put them under a single brand, consolidate HR and other expenses to develop economies of scale and really help additional bottom line."
    “Another way to look at it is, there's coffee shops all around the world, but there's also Starbucks Corporation (NASDAQ: SBUX), which started locally […] and developed really organically. But, they could just buy the local coffee shop, redesign it to the Starbucks brand, put their name on it… Now they have the distribution network, the backing of Starbucks, Starbucks will take care of their HR, their payroll — It's a more synergistic approach and a really value-add if they can consolidate any level of scale.”

    Elev8 Brands Inc (OTC: VATE) acquired O2 Breathe, LLC, a company supplying portable oxygen bars and aromatherapy inhalers.

Leave a Reply

Your email address will not be published. Required fields are marked *